hotStocksNewsغير مصنف

Incyte stops mid-stage study of colorectal cancer treatment

Jan 27 (Reuters) – Incyte Corp said on Wednesday that it would stop a mid-stage study on its combination cancer treatment after it failed to show sufficient levels of efficacy in an interim analysis.

اظهر المزيد

مقالات ذات صلة

شاهد أيضاً
إغلاق
زر الذهاب إلى الأعلى
إغلاق